CN105688233A - 一种医用消毒超声耦合剂 - Google Patents
一种医用消毒超声耦合剂 Download PDFInfo
- Publication number
- CN105688233A CN105688233A CN201610137753.6A CN201610137753A CN105688233A CN 105688233 A CN105688233 A CN 105688233A CN 201610137753 A CN201610137753 A CN 201610137753A CN 105688233 A CN105688233 A CN 105688233A
- Authority
- CN
- China
- Prior art keywords
- coupling agent
- herba
- grams
- ultrasonic coupling
- gram
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000007822 coupling agent Substances 0.000 title claims abstract description 48
- 230000000249 desinfective effect Effects 0.000 title abstract description 6
- 238000004659 sterilization and disinfection Methods 0.000 claims abstract description 50
- 239000003814 drug Substances 0.000 claims abstract description 23
- 229940079593 drug Drugs 0.000 claims abstract description 15
- 230000001954 sterilising effect Effects 0.000 claims description 48
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 30
- 238000012360 testing method Methods 0.000 claims description 27
- 238000002360 preparation method Methods 0.000 claims description 23
- 239000006228 supernatant Substances 0.000 claims description 18
- 238000000034 method Methods 0.000 claims description 14
- 239000000706 filtrate Substances 0.000 claims description 12
- 241000466346 Neoalsomitra integrifoliola Species 0.000 claims description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 9
- 230000008569 process Effects 0.000 claims description 8
- 239000012567 medical material Substances 0.000 claims description 7
- 238000011084 recovery Methods 0.000 claims description 6
- 239000000203 mixture Substances 0.000 claims description 5
- 230000000694 effects Effects 0.000 abstract description 10
- 238000003384 imaging method Methods 0.000 abstract description 3
- 238000007689 inspection Methods 0.000 abstract description 3
- 235000008216 herbs Nutrition 0.000 abstract 3
- 241000049624 Alisma plantago-aquatica subsp. orientale Species 0.000 abstract 1
- 241000221079 Euphorbia <genus> Species 0.000 abstract 1
- 235000006439 Lemna minor Nutrition 0.000 abstract 1
- 241000229150 Neoalsomitra Species 0.000 abstract 1
- 235000011925 Passiflora alata Nutrition 0.000 abstract 1
- 235000000370 Passiflora edulis Nutrition 0.000 abstract 1
- 235000011922 Passiflora incarnata Nutrition 0.000 abstract 1
- 240000002690 Passiflora mixta Species 0.000 abstract 1
- 235000013750 Passiflora mixta Nutrition 0.000 abstract 1
- 235000013731 Passiflora van volxemii Nutrition 0.000 abstract 1
- 240000000103 Potentilla erecta Species 0.000 abstract 1
- 235000016551 Potentilla erecta Nutrition 0.000 abstract 1
- 241000736239 Ruellia Species 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 230000007547 defect Effects 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 241000894006 Bacteria Species 0.000 description 17
- 239000000523 sample Substances 0.000 description 12
- 239000000499 gel Substances 0.000 description 10
- 206010011409 Cross infection Diseases 0.000 description 6
- 241000411851 herbal medicine Species 0.000 description 6
- 241000222122 Candida albicans Species 0.000 description 5
- 241000191967 Staphylococcus aureus Species 0.000 description 5
- 230000000844 anti-bacterial effect Effects 0.000 description 5
- 239000008280 blood Substances 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 5
- 229940095731 candida albicans Drugs 0.000 description 5
- 239000011550 stock solution Substances 0.000 description 5
- 208000010392 Bone Fractures Diseases 0.000 description 4
- 241000588724 Escherichia coli Species 0.000 description 4
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 4
- 230000008878 coupling Effects 0.000 description 4
- 238000010168 coupling process Methods 0.000 description 4
- 238000005859 coupling reaction Methods 0.000 description 4
- 208000015181 infectious disease Diseases 0.000 description 4
- 231100000614 poison Toxicity 0.000 description 4
- 239000003440 toxic substance Substances 0.000 description 4
- 229920000742 Cotton Polymers 0.000 description 3
- 206010012735 Diarrhoea Diseases 0.000 description 3
- 206010029803 Nosocomial infection Diseases 0.000 description 3
- 208000002193 Pain Diseases 0.000 description 3
- 208000003251 Pruritus Diseases 0.000 description 3
- 206010053476 Traumatic haemorrhage Diseases 0.000 description 3
- 238000003556 assay Methods 0.000 description 3
- 230000000052 comparative effect Effects 0.000 description 3
- 208000001848 dysentery Diseases 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 230000002070 germicidal effect Effects 0.000 description 3
- 208000035861 hematochezia Diseases 0.000 description 3
- 230000023597 hemostasis Effects 0.000 description 3
- 210000004877 mucosa Anatomy 0.000 description 3
- 239000013641 positive control Substances 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 238000005070 sampling Methods 0.000 description 3
- 230000008961 swelling Effects 0.000 description 3
- 238000010998 test method Methods 0.000 description 3
- 206010000087 Abdominal pain upper Diseases 0.000 description 2
- 208000004232 Enteritis Diseases 0.000 description 2
- 206010017076 Fracture Diseases 0.000 description 2
- 206010017553 Furuncle Diseases 0.000 description 2
- 208000000616 Hemoptysis Diseases 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 206010027514 Metrorrhagia Diseases 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 206010034038 Parotitis Diseases 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- 230000003187 abdominal effect Effects 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 238000004500 asepsis Methods 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 230000007797 corrosion Effects 0.000 description 2
- 238000005260 corrosion Methods 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 230000002500 effect on skin Effects 0.000 description 2
- 239000003480 eluent Substances 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 208000006454 hepatitis Diseases 0.000 description 2
- 231100000283 hepatitis Toxicity 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 201000007227 lymph node tuberculosis Diseases 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 235000013372 meat Nutrition 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 238000012797 qualification Methods 0.000 description 2
- 206010037844 rash Diseases 0.000 description 2
- 239000012488 sample solution Substances 0.000 description 2
- 235000014347 soups Nutrition 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 206010044008 tonsillitis Diseases 0.000 description 2
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 241001116389 Aloe Species 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 208000004429 Bacillary Dysentery Diseases 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- 240000009005 Calendula arvensis Species 0.000 description 1
- 235000007864 Calendula arvensis Nutrition 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 208000032928 Dyslipidaemia Diseases 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 206010015150 Erythema Diseases 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 208000004930 Fatty Liver Diseases 0.000 description 1
- 206010016807 Fluid retention Diseases 0.000 description 1
- 208000005577 Gastroenteritis Diseases 0.000 description 1
- 206010017915 Gastroenteritis shigella Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 206010019708 Hepatic steatosis Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 208000017170 Lipid metabolism disease Diseases 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- 201000005505 Measles Diseases 0.000 description 1
- 208000027530 Meniere disease Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000007443 Neurasthenia Diseases 0.000 description 1
- 206010030302 Oliguria Diseases 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 208000007107 Stomach Ulcer Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 206010000269 abscess Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 208000012873 acute gastroenteritis Diseases 0.000 description 1
- 235000011399 aloe vera Nutrition 0.000 description 1
- 201000009361 ascariasis Diseases 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 230000036523 atherogenesis Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 235000019636 bitter flavor Nutrition 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 230000009514 concussion Effects 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 239000000645 desinfectant Substances 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 208000000718 duodenal ulcer Diseases 0.000 description 1
- 206010013990 dysuria Diseases 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 231100000321 erythema Toxicity 0.000 description 1
- 210000003238 esophagus Anatomy 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 210000001508 eye Anatomy 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 208000010706 fatty liver disease Diseases 0.000 description 1
- 238000005187 foaming Methods 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 208000006750 hematuria Diseases 0.000 description 1
- 208000021760 high fever Diseases 0.000 description 1
- 230000000642 iatrogenic effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 239000006916 nutrient agar Substances 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 210000002640 perineum Anatomy 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 230000003285 pharmacodynamic effect Effects 0.000 description 1
- 208000008128 pulmonary tuberculosis Diseases 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000001047 pyretic effect Effects 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 210000000664 rectum Anatomy 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 201000003068 rheumatic fever Diseases 0.000 description 1
- 201000005404 rubella Diseases 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 201000005113 shigellosis Diseases 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 231100000240 steatosis hepatitis Toxicity 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000000472 traumatic effect Effects 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- DCXXMTOCNZCJGO-UHFFFAOYSA-N tristearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCC DCXXMTOCNZCJGO-UHFFFAOYSA-N 0.000 description 1
- 239000012137 tryptone Substances 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
- 208000019206 urinary tract infection Diseases 0.000 description 1
- 210000001215 vagina Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/22—Echographic preparations; Ultrasound imaging preparations ; Optoacoustic imaging preparations
- A61K49/222—Echographic preparations; Ultrasound imaging preparations ; Optoacoustic imaging preparations characterised by a special physical form, e.g. emulsions, liposomes
- A61K49/226—Solutes, emulsions, suspensions, dispersions, semi-solid forms, e.g. hydrogels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/19—Acanthaceae (Acanthus family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/42—Cucurbitaceae (Cucumber family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/47—Euphorbiaceae (Spurge family), e.g. Ricinus (castorbean)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/884—Alismataceae (Water-plantain family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/53—Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Medicinal Chemistry (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Engineering & Computer Science (AREA)
- Dispersion Chemistry (AREA)
- Physics & Mathematics (AREA)
- Acoustics & Sound (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Radiology & Medical Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
本发明属于医药领域,涉及一种医用超声耦合。针对现有技术不足,本发明提供的医用消毒超声耦合剂,其包括如下组分:浮萍、地锦草、半截叶、管仲、地皮消、赛金刚和泽泻。该医用消毒超声耦合剂所选药材配伍相宜,使用本发明医用消毒超声耦合剂进行超声检查,超声显像更加清晰,且具有良好的杀菌效果及使用安全性,具有很好的应用前景。
Description
技术领域
本发明属于医药技术领域,具体涉及一种医用消毒超声耦合剂。
背景技术
医用超声作为一种常规的影像学检查手段,超声探头会在检查工作中被频繁地应用,由于其对身体无损害、适用于多个年龄阶段,因此进行此项检查的人数众多。超声探头会频繁地同患者的皮肤或者黏膜进行直接接触,带菌量相对较多,且种类也比较繁杂,很可能成为引发医院感染的潜在危险因素。尽管医院感染无法根除,然通过有效的控制措施等可以降低感染的发生率,医用消毒超声耦合剂的应用便可以有效对在超声检查过程中所存在的感染高危因素进行避免,从而对因超声检查而发生的感染得到了有效的控制,避免了交叉感染,对降低医院感染的发生具有重要意义。同时,为了使图像清晰,在探头与皮肤或粘膜之间也需使用耦合剂。
现有技术中也公开了很多中药超声耦合剂,但是原料不易的、不精简、价格昂贵,增加了患者的就医成本。CN105343904A公开了一种医用彩超耦合剂及制备方法,其组方为:金盏草、白芷、茶油、地肤子、浮萍、油柑叶、梓叶、樟树叶、地皮消、红天葵、半截叶、管仲、樱桃、牛乳、海松子和芦荟,共计16味药物组成。
在进行超声检查的过程中,使用耦合剂对探头与人体组织之间的空气进行驱除,从而使高效、保真的超声传播通道得以建立,为现阶段超声技术在医药领域的一个进步。为此我们需要研发一种功效明确、配伍简单、原料易得的耦合剂,更好的为患者提供检查治疗服务。
发明内容
针对目前医用消毒超声耦合剂临床药物的不足,本发明的第一个目的在于提供一种医用消毒超声耦合剂,该医用消毒超声耦合剂由以下原料药制得:浮萍、地锦草、半截叶、管仲、地皮消、赛金刚和泽泻。该医用消毒超声耦合剂所选药材配伍相宜,具有更好的耦合作用,消毒杀菌好、无皮肤致敏性,避免了医源性的交叉感染;使用本发明医用消毒超声耦合剂进行超声检查,超声成像更加清晰。
优选的是,它由以下重量的原料药制得:浮萍20-30克、地锦草10-15克、半截叶10-15克、管仲5-10克、地皮消5-15克、赛金刚10-15克和泽泻10-20克。
更优选的是,它由以下重量的原料药制得:浮萍15克、地锦草13克、半截叶12克、管仲8克、地皮消10克、赛金刚12克和泽泻15克。
浮萍,辛,寒。归肺经。宣散风热,透疹,利尿。用于麻疹不透,风疹瘙痒,水肿尿少。《本经》载:“主暴热身痒,下水气,胜酒,长须发,止消渴。”
地锦草,辛,平。归肝、大肠经。清热解毒,凉血止血。用于痢疾,泄泻,咳血,尿血,便血,崩漏,疮疖痈肿。
半截叶,味微苦,性温。活血舒筋,燥湿杀虫。用于风湿性关节炎,跌打骨折,肝炎疟疾,蛔虫病。《云南中草药选》载:“燥湿,止血,消炎,生肌。治风湿腰痛,肝炎,肝硬化,肿瘤,跌打损伤,骨折。”
管仲,味苦,性平。清热消炎,凉血止血。用于赤白痢疾,肠炎胃痛,肺结核咯血,鼻衄便血,血崩,外伤出血,疔疮。《云南思茅中草药选》载:“清热止血,消炎收敛。治痢疾,肠炎,胃痛,咯血,吐血,外伤出血,痛经。”
地皮消,味甘、淡,性平;归肺、脾经。清热解毒,散瘀消肿。用于肺炎,扁桃体炎,腮腺炎,瘰疬,脓肿疮毒,骨折,创伤感染。《云南中草药》载:“清热解毒,消肿止痛。治骨折,淋巴结结核,腮腺炎,外伤出血。”
赛金刚,《云南思茅中草药选》:苦涩,寒。《云南思茅中草药选》:清热解毒,消炎杀菌,收敛止痛。治菌痢,急性肠胃炎,胃及十二指肠溃疡,脘腹痛,腹泻,尿路感染,高热,咽喉炎,扁桃体炎,便血,神经衰弱。
泽泻(根茎)又是传统的中药之一。中医理论认为其性寒,具有利水渗湿的功效;主治泄热通淋、小便不利、热淋涩痛、水肿胀满、泄泻、痰饮眩晕等症。现代医学研究,泽泻可降低血清总胆固醇及三酰甘油含量,减缓动脉粥样硬化形成;泽泻及其制剂现代还用于治疗内耳眩晕症、血脂异常、遗精、脂肪肝及糖尿病等。
本发明医用消毒超声耦合剂利用传统中药,配伍合理,诸药合用,不仅具有更好的耦合作用,还具有显著消毒杀菌之功效,避免了医源性交叉感染。可用于与皮肤、粘膜接触(包括阴道、眼部、食道、直肠和会阴部位)的超声操作。
制备本发明医用消毒超声耦合剂的方法,它包括以下步骤:
1)将处方量的中药材混合放入容器中,加药材重量的5-8倍的水,浸泡30分钟,煎煮2次,每次2小时,滤过,合并滤液,滤液减压浓缩至相对密度1.11-1.16的稠膏,该相对密度是在60℃下的检测结果,备用;
2)步骤1)所制稠膏中加入乙醇至含醇量为75%(v/v),静置12小时,取上清液,回收乙醇,上清液浓缩,备用;
3)将上述步骤2)所制的上清液浓缩后,用常规工艺制成凝胶制剂,即为所述的医用消毒超声耦合剂。
本发明上述医用消毒超声耦合剂可以进一步制备成临床上常用的药物制剂。优选的是,所述医用消毒超声耦合剂可以制备成凝胶剂或水剂。
该消毒超声耦合剂原液对载体上金黄色葡萄球菌、白色念珠菌、大肠埃希菌、铜绿假单胞菌均作用5min,杀灭对数值均>5.00。将该消毒超声耦合剂原液涂抹在病人皮肤上作用5min,对皮肤上自然菌的平均杀灭对数值>2.00。该消毒超声耦合剂对人体皮肤无刺激性,图像清晰,对超声探头无腐蚀。然而,随意改变组方,不能达到本发明的效果。由此,该消毒超声耦合剂具有良好的杀菌效果及使用安全性。
总之,本发明与现有技术相比具有预料不到的显著效果,其有益效果具体是:具有更好的耦合作用、对人体无毒无害、无皮肤刺激性,无油腻性,具有较好的杀菌消毒作用,不损伤探头,不会污染衣物易清洗,且制备简单,原料易得、配伍简单、成本低,适于大众化使用,使用本发明的耦合剂进行超声检查,超声显像更加清晰,具有很好的应用前景。
具体实施方式
以下通过具体实施方式进一步描述本发明,但本发明不仅仅限于以下实施例。在本发明的范围内或者在不脱离本发明的内容、精神和范围内,对本发明所述的医用消毒超声耦合剂进行适当改进、替换功效相同的组分,对于本领域技术人员来说是显而易见的,它们都被视为包括在本发明的范围之内。
第一部分,本发明医用消毒超声耦合剂的制备
实施例1水剂
处方:浮萍15克、地锦草13克、半截叶12克、管仲8克、地皮消10克、赛金刚12克和泽泻15克。
制备方法:
1)将处方量的中药材混合放入容器中,加药材重量的6倍的水,浸泡30分钟,煎煮2次,每次2小时,滤过,合并滤液,滤液减压浓缩至相对密度1.11-1.16的稠膏,该相对密度是在60℃下的检测结果,备用;
2)步骤1)所制稠膏中加入乙醇至含醇量为75%(v/v),静置12小时,取上清液,回收乙醇,上清液浓缩,备用;
3)将上述步骤2)所制的上清液浓缩后,用常规工艺制成凝胶制剂,即为所述的医用消毒超声耦合剂。
实施例2凝胶剂
处方:浮萍15克、地锦草13克、半截叶12克、管仲8克、地皮消10克、赛金刚12克和泽泻15克。
制备方法:
1)将处方量的中药材混合放入容器中,加药材重量的7倍的水,浸泡30分钟,煎煮2次,每次2小时,滤过,合并滤液,滤液减压浓缩至相对密度1.11-1.16的稠膏,该相对密度是在60℃下的检测结果,备用;
2)步骤1)所制稠膏中加入乙醇至含醇量为75%(v/v),静置12小时,取上清液,回收乙醇,上清液浓缩,备用;
3)将上述步骤2)所制的上清液浓缩后,用常规工艺制成凝胶制剂,即为所述的医用消毒超声耦合剂。
实施例3凝胶剂
处方:浮萍30克、地锦草15克、半截叶15克、管仲10克、地皮消15克、赛金刚15克和泽泻20克。
制备方法:
1)将处方量的中药材混合放入容器中,加药材重量的8倍的水,浸泡30分钟,煎煮2次,每次2小时,滤过,合并滤液,滤液减压浓缩至相对密度1.11-1.16的稠膏,该相对密度是在60℃下的检测结果,备用;
2)步骤1)所制稠膏中加入乙醇至含醇量为75%(v/v),静置12小时,取上清液,回收乙醇,上清液浓缩,备用;
3)将上述步骤2)所制的上清液浓缩后,用常规工艺制成凝胶制剂,即为所述的医用消毒超声耦合剂。
实施例4凝胶剂
处方:浮萍20克、地锦草10克、半截叶10克、管仲5克、地皮消5克、赛金刚10克和泽泻10克。
制备方法:
1)将处方量的中药材混合放入容器中,加药材重量的5倍的水,浸泡30分钟,煎煮2次,每次2小时,滤过,合并滤液,滤液减压浓缩至相对密度1.11-1.16的稠膏,该相对密度是在60℃下的检测结果,备用;
2)步骤1)所制稠膏中加入乙醇至含醇量为75%(v/v),静置12小时,取上清液,回收乙醇,上清液浓缩,备用;
3)将上述步骤2)所制的上清液浓缩后,用常规工艺制成凝胶制剂,即为所述的医用消毒超声耦合剂。
对比实施例1凝胶剂
处方:浮萍75克、地锦草10克、半截叶55克、管仲53克、地皮消60克、白芷75克和泽泻45克。
制备方法同实施例2。
第二部分,本发明医用消毒超声耦合剂的药效学考察
试验例1本发明医用消毒超声耦合剂的临床消毒效果
1)临床资料
作为辅助超声诊疗的耦合剂,选择超声诊疗患者100例临床观察,所有患者检查部位的皮肤均完整无病变、溃烂。其中男性57例,女性43例,年龄18-69岁,平均年龄51.3岁。病人随机分为两组,且两组患者资历基本一致,无显著差异,具有可比性。
2)皮肤消毒现场实验
检查前在其腹部,用无菌棉拭子沾湿采样液涂抹采样10cm×3cm范围作为消毒前对照。然后取医用超生消毒超声耦合剂原液3~5ml均匀涂抹于腹部,按探头检查顺序均匀涂抹5min后,用无菌棉拭子沾湿采样液按上述方法涂抹采样作为试验组。将采样棉拭头无菌剪入装有10ml中和剂(中和剂为D/E中和肉汤,为美国BD公司生产)的试管内,经充分震荡洗脱,取洗脱液接种培养,作活菌计数,计算杀灭对数值。
3)安全性观察
在每个被检查者使用该耦合剂之后,收集不良反应(刺激或瘙痒等),观察皮肤变化(红疹、斑块、起泡等局部反应);同时观察超声探头是否出现腐蚀、溶胀情况及声像图效果。
4)结果
结果表明,将该消毒超声耦合剂原液涂抹在病人皮肤上作用5min,对皮肤上自然菌的平均杀灭对数值2.06,消毒前平均检出菌数为189cfu/cm2。该消毒超声耦合剂对人体皮肤无刺激性,对超声探头无腐蚀,图像清晰。
同条件下,对照Ⅱ组(本发明对比实施例1制备的医用消毒超声耦合剂)耦合剂原液涂抹在病人皮肤上作用5min,对皮肤上自然菌的平均杀灭对数值1.03,消毒前平均检出菌数为186cfu/cm2。该消毒超声耦合剂对人体皮肤无刺激性,对超声探头腐蚀较小,也可长期使用,图像较为清晰。
由此说明,该消毒超声耦合剂具有良好的杀菌效果及使用安全性。
试验例2
1)试验菌株
试验菌株为金黄色葡萄球菌(ATCC6538)、大肠杆菌(8099)、铜绿假单胞菌(ATCC15442)、白色念珠菌(ATCC10231),由医院检验科提供。
2)载体定量杀菌试验方法
(1)菌悬液及染菌载体制备
将各试验菌经分离纯化培养,取单个典型菌落接种营养琼脂培养基斜面,培养24h用其新鲜斜面培养物。用营养肉汤洗下斜面上菌苔,经充分震荡混匀并用浓度为1000mg/L的胰蛋白胨生理盐水(TPS)稀释成含菌量1.0×108~5.0×108cfu/ml试验菌液。分别取20菌悬液滴染在lcm×1cm无菌布片上,经37℃温箱烘烤15min,即制成染菌载体,回收菌量范围5.0×105~5.0×106cfu/片。
(2)中和剂鉴定实验
以金黄色葡萄球菌、白色念珠菌为试验菌,设计6组,按载体定量杀菌试验方法进行。结果第1组有极少量菌生长或无菌生长;第2组有菌生长且明显少于3、4、5组,但多于第1组;第3、4、5组菌数接近且符合阳性对照组菌数要求,第6组无菌生长。符合上述条件,试验重复3次结果一致,判定所选中和剂及其浓度适宜。
(3)杀菌试验
采用载体定量杀菌试验方法,在20%条件下进行试验。按每个菌片5.0ml用量将试验用消毒剂分装在无菌平皿内,将菌片完全浸泡在消毒超声耦合剂内(分三组,阳性对照用TPS)。作用至规定时间,取出菌片投人到装有5.0ml中和剂的试管内,中和作用10min后经充分震荡洗脱,取洗脱液接种培养,进行活菌计数,计算平均杀灭对数值。所有试验至少重复3次。
三组分别是实验组、对照Ⅰ组、对照Ⅱ组。其中实验组为本发明实施例2制备的医用消毒超声耦合剂;对比Ⅰ组为阳性对照用TPS;对照Ⅱ组为本发明对比实施例1制备的医用消毒超声耦合剂。
3)试验结果
经3次试验结果表明,用D/E中和肉汤作为该消毒超声耦合剂的中和剂,可有效中和其对试验菌的残留作用,中和剂本身及其中和产物对试验菌生长及培养基无影响(表1)。
表1.耦合剂中和剂鉴定结果
载体浸泡定量杀菌试验结果表明,用受试剂作用5min,对金黄色葡萄球菌、大肠埃希菌、铜绿假单胞菌、白色念珠菌的平均杀灭对数值均>5.00。而对照Ⅱ组用受试剂作用5min,对金黄色葡萄球菌、大肠埃希菌、铜绿假单胞菌、白色念珠菌的平均杀灭对数值均≥4.00。具体杀菌试验结果见表2。
表2.耦合剂杀菌试验结果
同时,本发明在涂布性能、分辨率、超声图形清晰程度比较:试验组的耦合剂均质地细腻均匀,不含气泡,稠度适宜、使用时不会流淌、易挤出,涂布性能良好,不易干燥,探头滑动良好,分辨率高,超声图像清晰,但是对照Ⅱ组,出现少量气泡。另外,试验组和对照Ⅱ组均无明显皮肤黏膜刺激;长期使用后,对探头也没有明显腐蚀。
综上,本发明提供了一种含中药成分的医用消毒超声耦合剂及其制备方法,该耦合剂所选中药材组方精简,配伍合理,具有耦合及抗菌消毒的显著功效,无毒副作用,安全可靠,值得临床推广应用。另外,本发明提供的制备中药组合物的方法,利用现代制备工艺快速提取该组合物的有效成分,该方法简单易行,适合大批量推广生产。
Claims (5)
1.一种医用消毒超声耦合剂,其特征在于,它由以下原料药制得:浮萍、地锦草、半截叶、管仲、地皮消、赛金刚和泽泻。
2.如权利要求1所述的医用消毒超声耦合剂,其特征在于,它由以下重量的原料药制得:浮萍20-30克、地锦草10-15克、半截叶10-15克、管仲5-10克、地皮消5-15克、赛金刚10-15克和泽泻10-20克。
3.如权利要求1所述的医用消毒超声耦合剂,其特征在于,它由以下重量的原料药制得:浮萍15克、地锦草13克、半截叶12克、管仲8克、地皮消30克、赛金刚10克和泽泻15克。
4.如权利要求1-3所述的组合物,其特征在于所述医用消毒超声耦合剂优选为凝胶剂或水剂。
5.一种制备如权利要求4所述的医用消毒超声耦合剂的方法,其特征在于,它包括以下步骤:
1)将处方量的中药材混合放入容器中,加药材重量的5-8倍的水,浸泡30分钟,煎煮2次,每次2小时,滤过,合并滤液,滤液减压浓缩至相对密度1.11-1.16的稠膏,该相对密度是在60℃下的检测结果,备用;
2)步骤1)所制稠膏中加入乙醇至含醇量为75%(v/v),静置12小时,取上清液,回收乙醇,上清液浓缩,备用;
3)将上述步骤2)所制的上清液浓缩后,用常规工艺制成凝胶制剂,即为所述的医用消毒超声耦合剂。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610137753.6A CN105688233A (zh) | 2016-03-10 | 2016-03-10 | 一种医用消毒超声耦合剂 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610137753.6A CN105688233A (zh) | 2016-03-10 | 2016-03-10 | 一种医用消毒超声耦合剂 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN105688233A true CN105688233A (zh) | 2016-06-22 |
Family
ID=56220406
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610137753.6A Pending CN105688233A (zh) | 2016-03-10 | 2016-03-10 | 一种医用消毒超声耦合剂 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105688233A (zh) |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101773673A (zh) * | 2010-03-18 | 2010-07-14 | 薛海燕 | 医用消毒超声耦合剂及其制备方法 |
CN103341184A (zh) * | 2013-07-31 | 2013-10-09 | 王玉梅 | 一种超声耦合剂及制备方法 |
CN103751812A (zh) * | 2014-01-19 | 2014-04-30 | 孙方利 | 一种超声耦合剂及制备方法 |
CN103933585A (zh) * | 2014-04-24 | 2014-07-23 | 王庆华 | 一种医用消毒超声耦合剂及其制备方法 |
CN104888237A (zh) * | 2015-06-26 | 2015-09-09 | 长春呈实健康实业有限公司 | 医用消毒超声耦合剂及其制备方法 |
-
2016
- 2016-03-10 CN CN201610137753.6A patent/CN105688233A/zh active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101773673A (zh) * | 2010-03-18 | 2010-07-14 | 薛海燕 | 医用消毒超声耦合剂及其制备方法 |
CN103341184A (zh) * | 2013-07-31 | 2013-10-09 | 王玉梅 | 一种超声耦合剂及制备方法 |
CN103751812A (zh) * | 2014-01-19 | 2014-04-30 | 孙方利 | 一种超声耦合剂及制备方法 |
CN103933585A (zh) * | 2014-04-24 | 2014-07-23 | 王庆华 | 一种医用消毒超声耦合剂及其制备方法 |
CN104888237A (zh) * | 2015-06-26 | 2015-09-09 | 长春呈实健康实业有限公司 | 医用消毒超声耦合剂及其制备方法 |
Non-Patent Citations (2)
Title |
---|
牛凤岐 等: "《中华人民共和国医药行业标准》", 26 January 2016 * |
董方言 主编: "《现代实用中药新剂型新技术》", 30 April 2001, 人民卫生出版社 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN109568206B (zh) | 一种专用于女性的抑菌组合物及洗液和制备方法 | |
CN103751812B (zh) | 一种超声耦合剂及制备方法 | |
CN103341184B (zh) | 一种超声耦合剂及制备方法 | |
CN106214573B (zh) | 一种医用免洗手护肤消毒液及其制备方法 | |
CN105288458A (zh) | 一种医用消毒液 | |
CN105053073A (zh) | 一种用于手术室消毒的中药消毒液及制备方法 | |
CN108888758A (zh) | 胶原蛋白妇科洗液及其制备方法 | |
CN109010685A (zh) | 一种妇科用抑菌泡沫气雾剂及其制备方法 | |
CN104645360A (zh) | 一种b超用耦合剂及其制备方法 | |
CN106259501A (zh) | 一种手术室专用杀菌消毒液及制备方法 | |
CN109602813A (zh) | 一种抑菌凝胶剂及其制备方法 | |
CN105613612A (zh) | 一种用于重症监护室消毒的药剂及制备方法 | |
CN104645117A (zh) | 一种检验科用中药消毒液 | |
CN105688233A (zh) | 一种医用消毒超声耦合剂 | |
CN103599437B (zh) | 一种治疗阴道炎的中药药液 | |
CN105233184A (zh) | 一种含有中药成分的消毒液 | |
CN1191066C (zh) | 外用消毒剂 | |
CN104304352A (zh) | 一种用于手术室空气消毒的中药药剂及制备方法 | |
CN105770918A (zh) | 一种医用超声耦合剂 | |
CN105193770B (zh) | 一种治疗深度褥疮合并骨感染的涂膜剂及其制备方法 | |
CN104800422A (zh) | 一种治疗腹股沟癣的茶树精油及制备方法 | |
CN109512743A (zh) | 一种天然抑菌组合物、男士抑菌洗液及其制备方法和应用 | |
CN105660742A (zh) | 一种健康体检用中药消毒液 | |
CN108739884A (zh) | 一种中草药消毒剂 | |
CN108498672A (zh) | 一种医院用消毒液及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20160622 |
|
RJ01 | Rejection of invention patent application after publication |